- Filed
- Oct 10, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Oct 10, 2024 | 1.6M sh |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $2.64M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $2.33M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $2.64M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $2.42M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $500.81K |
| Current Assets | Q1 2024 · Dec 31, 2023 | $435.78K |
| Total Assets | Q1 2024 · Mar 31, 2024 | $6.34M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $6.28M |
| Net Income | Q1 2024 · Dec 31, 2023 | −$3.98M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$399.89K |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 867.94K sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | $19.35K |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $6.52M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $6.78M |
| Eps Diluted restated | Q1 2024 · Mar 31, 2023 | −$0.46 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | −$0.46 |
| Sga Expense restated | Q1 2024 · Mar 31, 2023 | $185.79K |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$399.42K |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $307.99K |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $689.46K |